investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
Tait D Shanafelt
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Elizaveta V Benevolenskaya
RBP2 Regulation Through Differential Recruitment to Genomic Loci
Leukaemia
Hematology and hematologic malignancies
Michael R Green
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
Leukaemia
Hematology and hematologic malignancies
Alan Rein
Retrovirus Assembly and Maturation
Leukaemia
Hematology and hematologic malignancies
Thomas Waldmann
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
Leukaemia
Hematology and hematologic malignancies
Danilo Perrotti
Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival
Leukaemia
Hematology and hematologic malignancies
Daniel Fowler
Combination Gene Therapy and Th1/Th2 Therapy
Leukaemia
Hematology and hematologic malignancies
Bruno Calabretta
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
Leukaemia
Hematology and hematologic malignancies
Alan B. Cantor
Regulation of RUNX1 Multiprotein Complex Formation during Hematopoiesis
Leukaemia
Hematology and hematologic malignancies
Robert Stanley
Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms
Leukaemia
Hematology and hematologic malignancies
